Mastodon
Kliniken &… Institute Global Health Staff Yerlikaya, Seda

Seda Yerlikaya, PhD

Junior Research Group Leader

Seda is a molecular biologist with postgraduate training in molecular life sciences (MSc, PhD) and global health (MSc) from the University of Geneva, Switzerland. She worked at FIND, the Global Alliance for Diagnostics, in various capacities from 2015 to 2021.She joined the Denkinger group in February 2021 and has since worked as the technology lead for the NIH-funded R2D2 TB Network and the USAID-funded SMART4TB projects. She has experience and knowledge in infectious disease diagnostics, clinical research, and global health issues, especially in the areas of tuberculosis and malaria.


2017: MSc in Global Health, Global Studies Institute, UNIGE, Geneva, Switzerland
2013: PhD in Basic and Applied Molecular Life Sciences, Department of Molecular Biology, UNIGE, Geneva, Switzerland
2008: MSc in Basic and Applied Molecular Life Sciences, Department of Molecular Biology, UNIGE, Geneva, Switzerland
2007: BSc in Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
 

Projects & Grants

  • NIH, Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network), 2020-2025, https://www.r2d2tbnetwork.org/
  • USAID, Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB), 2021-2026, https://tbcenter.jhu.edu/smart4tb/
  • GLOHRA, Development of a novel, easy-to-use digital tuberculosis screening tool informed by machine learning approaches (AI TB Screening Tool), 2022-2024

Publications

  • Yerlikaya S, Holtgrewe L, Broger T, Isaacs C, Nahid P, Cattamanchi A, Denkinger CM. Innovative COVID-19 Point-of-Care Diagnostics Suitable for Tuberculosis Diagnosis:  A Scoping Review Protocol. BMJ Open, 2023.
  • Tan AF, Sakam SSB, Rajahram GS, William T, Isnadi M, Daim S, Barber BE, Kho S, Sutherland CJ, Anstey NM, Yerlikaya S, van Schalkwyk DA, Grigg MJ. Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for Plasmodium knowlesi and P. falciparum. Front Cell Infect Microbiol. 2022.
  • Yerlikaya S, Owusu E, Frimpong A, DeLisle RK, Ding X. A dual, systematic approach to malaria diagnostic biomarker discovery. Clin Infect Dis. 2021.    
    MacLean E, Broger T, Yerlikaya S, Fernandez-Carballo BL, Pai M, Denkinger CM. A systematic review of biomarkers to detect active tuberculosis. Nat Microbiol. 2019 May;4(5):748-758.
  • Yerlikaya S, Campillo A, Gonzalez IJ. A Systematic Review: Performance of Rapid Diagnostic Tests for the Detection of Plasmodium knowlesi, Plasmodium malariae, and Plasmodium ovale Monoinfections in Human Blood. J Infect Dis. 2018 Jun 20;218(2):265-276.
  • Yerlikaya S, Broger T, MacLean E, Pai M, Denkinger C. Tuberculosis Biomarker Database: The Key to Novel TB Diagnostics. Int J Infect Dis. 2017.
  • Yerlikaya S, Meusburger M, Anrather D, Ammerer G, Loewith R. TORC1 and TORC2 converges to regulate Rps6 phosphorylation via Ypk1/2/3 kinases in budding yeast. Mol Biol Cell. 2016 Jan 15;27(2):397-409.

pubmed.ncbi.nlm.nih.gov